Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status

被引：24

作者：

Foulkes, WD

Goffin, J

Brunet, JS

Bégin, LR

Wong, N

Chappuis, PO

机构：

[1] Sir MB Davis Jewish Gen Hosp, Program Canc Genet, Dept Oncol, Montreal, PQ, Canada

[2] Sir MB Davis Jewish Gen Hosp, Program Canc Genet, Dept Human Genet, Montreal, PQ, Canada

[3] Sir MB Davis Jewish Gen Hosp, Dept Pathol, Montreal, PQ, Canada

[4] Sir MB Davis Jewish Gen Hosp, Canc Prevent Ctr, Montreal, PQ, Canada

[5] McGill Univ, Ctr Hlth, Inst Res, Dept Med, Montreal, PQ, Canada

[6] Algorithme Pharma, Montreal, PQ, Canada

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2002年 / 94卷 / 19期

关键词：

D O I：

10.1093/jnci/94.19.1504-a

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1504 / 1506

页数：3

共 8 条

[1]

Fan SJ, 2002, CANCER RES, V62, P141

[2] Role of direct interaction in BRCA1 inhibition of estrogen receptor activity [J].

Fan, SJ ;

Ma, YX ;

Wang, CG ;

Yuan, RQ ;

Meng, QH ;

Wang, JA ;

Erdos, M ;

Goldberg, ID ;

Webb, P ;

Kushner, PJ ;

Pestell, RG ;

Rosen, EM .

ONCOGENE, 2001, 20 (01) :77-87

[3] Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines [J].

Ferlini, C ;

Scambia, G ;

Marone, M ;

Distefano, M ;

Gaggini, C ;

Ferrandina, G ;

Fattorossi, A ;

Isola, G ;

Panici, PB ;

Mancuso, S .

BRITISH JOURNAL OF CANCER, 1999, 79 (02) :257-263

[4] Tumour biological features of BRCA1-induced breast and ovarian cancer [J].

Johannsson, OT ;

Idvall, I ;

Anderson, C ;

Borg, A ;

Barkardottir, RB ;

Egilsson, V ;

Olsson, H .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (03) :362-371

[5]

Karp SE, 1997, CANCER-AM CANCER SOC, V80, P435, DOI 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO

[6]

2-Y

[7] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial [J].

King, MC ;

Wieand, S ;

Hale, K ;

Lee, M ;

Walsh, T ;

Owens, K ;

Tait, J ;

Ford, L ;

Dunn, BK ;

Costantino, J ;

Wickerham, L ;

Wolmark, N ;

Fisher, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18) :2251-2256

[8] Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers:: a case-control study [J].

Narod, SA ;

Brunet, JS ;

Ghadirian, P ;

Robson, M ;

Heimdal, K ;

Neuhausen, SL ;

Stoppa-Lyonnet, D ;

Lerman, C ;

Pasini, B ;

de los Rios, P ;

Weber, B ;

Lynch, H .

LANCET, 2000, 356 (9245) :1876-1881

← 1 →